Novel antagonists of ∝4&bgr;1 integrin and/or ∝4&bgr;7 integrin of the general Formula I: wherein R1, R2, R5, L1, L2, Rb, W and Z are as defined in any one of claims
1
to
13,
A represents —CH— or a nitrogen atom, and p is from 0 to 4.
Novel antagonists of α4β1 integrin and/or α4β7 integrin are described in this application.
本申请中描述了α4β1整合素和/或α4β7整合素的新型拮抗剂。
UREA DERIVATIVES AS INTEGRIN ALPHA 4 ANTAGONISTS
申请人:Laboratorios Almirall, S.A.
公开号:EP1383750B1
公开(公告)日:2007-09-26
US7253171B2
申请人:——
公开号:US7253171B2
公开(公告)日:2007-08-07
Tritium labelling of bromhexine via amide reduction with LiB3H4
作者:Uffe S. Larsen、Mikael Begtrup、Lars Martiny
DOI:10.1002/jlcr.938
日期:2005.5
The mucolytic agent bromhexine is useful in the evaluation of the performance of inductively coupled plasma mass spectrometry (ICP-MS) as compared to radiolabelling. A prerequisite for this comparison is access to radiolabelled bromhexine. [3H2]-bromhexine was synthesized in three steps introducing tritium in the final step by reduction of 2-amino-3,5-dibromo-N-methyl-N-cyclohexylbenzamide. Good chemical